{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:55:09Z","timestamp":1787241309100,"version":"build-2736575974"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"unspecified","delay-in-days":158,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,5,27]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Guillain-Barr\u00e9 Syndrome (GBS) is a life-threatening neurological disorder with limited data from sub-Saharan Africa. This study describes the clinical features, outcomes and predictors of mortality among GBS patients at Kenyatta National Hospital in Nairobi, Kenya.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study used retrospective data from patient files obtained from the Health Information Department from 2014 to 2023 on 207 GBS patients. A census of all available patient files meeting inclusion criteria was done. Demographic and clinical data were collected; descriptive and correlation analyses were performed using IBM SPSS Statistics V.25.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The male to female ratio was 1.01:1. The median age was 21 years. A quarter of cases were in the 0\u20135 years age group. HIV and hypertension were the most common comorbidities, particularly in females. Clinical manifestations included hyporeflexia, hypotonia and sensory loss. Significant morbidity was observed, with 25.7% experiencing respiratory complications and 35.4% requiring intensive care. Female patients had increased mortality risk (adjusted OR (aOR)=4.03, 95% CI: 1.15 to 14.11, p=0.029). HIV-positive females had over sevenfold higher odds of death (aOR 7.21, 95%\u2009CI: 1.56 to 33.36, p=0.011), while intravenous immunoglobulin (IVIg) use reduced mortality by 75% (aOR 0.25, 95%\u2009CI: 0.08 to 0.85, p=0.026).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights GBS\u2019s demographic, clinical and outcome aspects in Kenya. GBS predominates in young individuals. Females experience higher comorbidity and mortality rates. Improving access to IVIg, intensive care unit and early supportive management is essential. Further research is needed to explore gender-based mortality differences and age-related morbidity variations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001074","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T15:35:12Z","timestamp":1749396912000},"page":"e001074","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Demographic and clinical characteristics of Guillain-Barr\u00e9 syndrome at Kenyatta National Hospital, Kenya"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5714-3581","authenticated-orcid":false,"given":"Stephen Kivuva","family":"Muindi","sequence":"first","affiliation":[{"name":"Medicine and Surgery, University of Nairobi Faculty of Health Sciences, Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-7065","authenticated-orcid":false,"given":"Mohamed","family":"Onyango","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-0821","authenticated-orcid":false,"given":"Moses Muia","family":"Masika","sequence":"additional","affiliation":[{"name":"Medical Microbiology and Immunology, University of Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,8]]},"reference":[{"key":"2025072811344986000_7.1.e001074.1","unstructured":"Nguyen TP , Taylor RS . Guillain-barre syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2024."},{"key":"2025072811344986000_7.1.e001074.2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-13-195","article-title":"Guillain-Barr\u00e9 syndrome as a cause of acute flaccid paralysis in Iraqi children: a result of 15 years of nation-wide study","volume":"13","author":"Jasem","year":"2013","journal-title":"BMC Neurol"},{"key":"2025072811344986000_7.1.e001074.3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barr\u00e9 syndrome associated with preceding hepatitis E virus infection","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology (ECronicon)"},{"key":"2025072811344986000_7.1.e001074.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00467-y"},{"key":"2025072811344986000_7.1.e001074.5","doi-asserted-by":"publisher","DOI":"10.1159\/000184748"},{"key":"2025072811344986000_7.1.e001074.6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology (ECronicon)"},{"key":"2025072811344986000_7.1.e001074.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314485"},{"key":"2025072811344986000_7.1.e001074.8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain (Bacau)"},{"key":"2025072811344986000_7.1.e001074.9","article-title":"Significance of Brighton Criteria in the Early Diagnosis and Management of Guillain-Barr\u00e9 Syndrome","volume":"12","author":"Ghazanfar","year":"2020","journal-title":"Cureus"},{"key":"2025072811344986000_7.1.e001074.10","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15204"},{"key":"2025072811344986000_7.1.e001074.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.01.016"},{"key":"2025072811344986000_7.1.e001074.12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3988\/jcn.2022.18.1.48","article-title":"Incidence, Disability, and Mortality in Patients With Guillain-Barr\u00e9 Syndrome in Korea: A Nationwide Population-Based Study","volume":"18","author":"Yi","year":"2022","journal-title":"J Clin Neurol"},{"key":"2025072811344986000_7.1.e001074.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.08.005"},{"key":"2025072811344986000_7.1.e001074.14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038411","article-title":"Sex differences in Guillain Barr\u00e9 syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis","volume":"13","author":"McCombe","year":"2022","journal-title":"Front Immunol"},{"key":"2025072811344986000_7.1.e001074.15","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czt075"},{"key":"2025072811344986000_7.1.e001074.16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5152\/TJAR.2013.51","article-title":"Guillain-Barr\u00e9 Syndrome and Human Immunodeficiency Virus","volume":"42","author":"Girgin","year":"2014","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"2025072811344986000_7.1.e001074.17","doi-asserted-by":"publisher","DOI":"10.1159\/000324710"},{"key":"2025072811344986000_7.1.e001074.18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain-Barr\u00e9 Syndrome: Campylobacter jejuni Predominates","volume":"23","author":"Finsterer","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025072811344986000_7.1.e001074.19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2024.03.034","article-title":"Comparison of Clinical Features, Short-Term Outcome of Guillain-Barr\u00e9 Syndrome Between Adults and Children: A Retrospective Study in Vietnam","volume":"155","author":"Dang","year":"2024","journal-title":"Pediatr Neurol"},{"key":"2025072811344986000_7.1.e001074.20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"The Lancet"},{"key":"2025072811344986000_7.1.e001074.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9"},{"key":"2025072811344986000_7.1.e001074.22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","article-title":"Dysautonomia in Guillain-Barr\u00e9 Syndrome: Prevalence, Clinical Spectrum, and Outcomes","volume":"32","author":"Chakraborty","year":"2020","journal-title":"Neurocrit Care"},{"key":"2025072811344986000_7.1.e001074.23","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/ene.15500","article-title":"Outcome of Guillain-Barr\u00e9 syndrome following intravenous immunoglobulin compared to natural course","volume":"29","author":"Kalita","year":"2022","journal-title":"Eur J Neurol"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:34:57Z","timestamp":1753727697000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,8]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjno-2025-001074"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001074","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}